https://www.prnewswire.co.uk/news-releases/resverlogix-randomizes-first-patient-in-taiwanchina-portion-of-the-phase-3-betonmace-clinical-trial-633576763.html
Resverlogix Randomizes First Patient in Taiwan/China Portion of the Phase 3 BETonMACE Clinical Trial
/PRNewswire/ -- Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) today announced that the first patient has been randomized in Taiwan in the...